FDA, COVID-19 vaccine and Novavax
Digest more
Novavax's closely watched COVID-19 vaccine is on track for full approval ... about vaccine safety. With full FDA approval, Novavax would have permission to keep its shot on the market indefinitely.
The head of the Food and Drug Administration said the agency will soon unveil a new framework detailing what companies must do to seek approval of vaccines, a move that comes as the Trump administration has introduced uncertainty into the annual process for green-lighting updated coronavirus shots traditionally offered in the fall.